Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 2 | 0 | 0 | 2 |
AR protein | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
ClpP | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
GLS protein | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
polyprotein | 2 | 0 | 0 | 2 |
arylsulfatase A | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 2 | 0 | 0 | 2 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
estrogen nuclear receptor alpha | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
IDH1 | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 2 | 0 | 0 | 2 |
geminin | 2 | 0 | 0 | 2 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 2 | 0 | 0 | 2 |
Cytochrome P450 3A5 | 0 | 0 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
67.9K protein | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Bile salt export pump | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 3 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |